Related Experiment Video
Updated: Aug 28, 2026

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Growth factors and receptors in cancer
1ICRF, University of Oxford, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, UK.
Abstract:
There have been a number of recent developments in mechanisms of action of growth factors and their receptors with particular relevance to cancer. The tyrosine kinase receptor family, in particular, has been shown to be important in tumour growth. These receptors are the products of oncogenes, or can interact with other oncogene pathways. Thus, antibodies to either the receptor or its ligand can be used as therapeutic agents. Peptide analogues of ligands that can block receptor activation are also potential therapeutic agents.
Insights
Recent advancements reveal growth factor receptor mechanisms crucial for cancer. Targeting tyrosine kinase receptors, implicated in tumor growth, offers new therapeutic strategies using antibodies or peptide ligands.
Area of Science:
- Oncology and Molecular Biology
- Cancer Research
- Signal Transduction
Background:
- Growth factors and their receptors play critical roles in cellular processes.
- The tyrosine kinase receptor family is frequently implicated in tumor development and progression.
- These receptors are often linked to oncogene activation and signaling pathways.
Purpose of the Study:
- To review recent developments in the mechanisms of action of growth factors and their receptors.
- To highlight the relevance of these mechanisms, particularly tyrosine kinase receptors, in cancer.
- To discuss potential therapeutic strategies targeting these pathways.
Main Methods:
- Literature review of recent developments in growth factor receptor signaling.
- Analysis of the role of tyrosine kinase receptors in oncogenesis.
- Exploration of antibody and peptide-based therapeutic approaches.
Main Results:
- Tyrosine kinase receptors are key mediators of tumor growth.
- These receptors are products of oncogenes or interact with oncogenic pathways.
- Antibodies and peptide analogues targeting these receptors show therapeutic potential.
Conclusions:
- Understanding growth factor receptor mechanisms is vital for cancer therapy.
- Targeting tyrosine kinase receptors offers promising avenues for cancer treatment.
- Therapeutic agents like antibodies and peptide ligands can disrupt tumor growth signaling.
Related Concept Videos
Cancer
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

